Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113754650A reveals a novel route for rosuvastatin calcium intermediates, drastically reducing cis-isomer impurities and enhancing pharmaceutical manufacturing efficiency.
Novel hydrolysis process for posaconazole ensures high purity and eliminates heavy metal residues offering significant supply chain advantages for global pharmaceutical manufacturers.
Patent CN104926734B reveals efficient flibanserin synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Analyzing patent CN104561217B for advanced steroid synthesis. Delivers high-purity intermediates with reduced environmental impact and scalable manufacturing capabilities for global supply chains.
Advanced synthesis of 3-benzazepines via novel cyclization and reduction routes. Offers cost reduction in API manufacturing and scalable production for CNS disorder treatments.
Patent CN109651368A details a scalable two-step route for spiro compounds offering significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN106748642B reveals novel halogenation route for WXFQ-65. Enhances solubility and safety for scalable pharmaceutical intermediates manufacturing supply chains.
Novel 3-step route for Ticagrelor Intermediate A via Zn reduction. High purity, cost-effective API manufacturing solution.
Advanced two-step synthesis of ethylmethylcarbamoyl chloride via amide reduction. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104651243B details high-yield biocatalytic synthesis of (R)-1,3-butanediol. Offers superior purity and cost-effective supply chain solutions for antibiotic manufacturing.
Patent CN109762768B details a novel Bacillus B8W22 strain for producing high-purity pharmaceutical intermediates with superior stereoselectivity and reduced environmental impact.
Patent CN112110801B details a cost-effective nickel-catalyzed method for gamma-aryl ketones, offering significant supply chain advantages for pharmaceutical intermediate manufacturing.
Patent CN115536720B reveals plant-based cholic acid intermediate synthesis. Eliminates animal extraction risks. Offers scalable pharmaceutical intermediates manufacturing solutions.
Advanced chemical synthesis of Plesiomonas shigelloides O51 antigen oligosaccharides ensures high purity and scalable supply for next-generation vaccine intermediates.
Novel enzymatic route for (R)-HPBE offers high purity and yield. Reduces cost and supply chain risks for lisinopril intermediate manufacturing globally.
Patent CN107586796A reveals enzymatic synthesis for high-purity chiral amines. Offers scalable cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN105732373A details high-purity (R)-HPBE production via enzymatic reduction. This method offers significant supply chain and cost advantages for pharmaceutical intermediates manufacturing.
Patent CN102978251A reveals a low-cost enzymatic route for L-tert-leucine. Achieve >99% optical purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104926813A enables high-yield asymmetric catalysis. Delivers supply chain stability and cost advantages for pharmaceutical intermediates manufacturing globally.
Patent CN104370830B enables high-yield 5-trifluoromethyl uracil production. Offers cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain.